MovDisordV3, Main, Exploration, bibRecord, 003587

Aripiprazole associated with severe exacerbation of Parkinson's disease

Identifieur interne : 003587 ( Main/Exploration ); précédent : 003586; suivant : 003588

Aripiprazole associated with severe exacerbation of Parkinson's disease

Auteurs : Mirdhu Wickremaratchi [Royaume-Uni] ; Huw R. Morris [Royaume-Uni] ; Imad M. Ali [Royaume-Uni]

Source :

Movement Disorders [ 0885-3185 ] ; 2006-09.

RBID : ISTEX:33AEC66DA30E8194BEE3C6A21657E9A6B7D7C457

English descriptors

KwdEn :
- Antipsychotic Agents (adverse effects), Antipsychotic Agents (therapeutic use), Dyskinesia, Drug-Induced (diagnosis), Female, Humans, Middle Aged, Neurologic Examination (drug effects), Parkinson Disease (drug therapy), Parkinsonian Disorders (chemically induced), Parkinsonian Disorders (diagnosis), Piperazines (adverse effects), Piperazines (therapeutic use), Psychotic Disorders (drug therapy), Quinolones (adverse effects), Quinolones (therapeutic use).
MESH :
- chemical , adverse effects : Antipsychotic Agents, Piperazines, Quinolones.
- chemical , therapeutic use : Antipsychotic Agents, Piperazines, Quinolones.
- chemically induced : Parkinsonian Disorders.
- diagnosis : Dyskinesia, Drug-Induced, Parkinsonian Disorders.
- drug effects : Neurologic Examination.
- drug therapy : Parkinson Disease, Psychotic Disorders.
- Female, Humans, Middle Aged.

Url:

https://api.istex.fr/document/33AEC66DA30E8194BEE3C6A21657E9A6B7D7C457/fulltext/pdf

DOI: 10.1002/mds.21025

Affiliations:

Royaume-Uni

Le document en format XML

<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Aripiprazole associated with severe exacerbation of Parkinson's disease</title>
<author><name sortKey="Wickremaratchi, Mirdhu" sort="Wickremaratchi, Mirdhu" uniqKey="Wickremaratchi M" first="Mirdhu" last="Wickremaratchi">Mirdhu Wickremaratchi</name>
</author>
<author><name sortKey="Morris, Huw R" sort="Morris, Huw R" uniqKey="Morris H" first="Huw R." last="Morris">Huw R. Morris</name>
</author>
<author><name sortKey="Ali, Imad M" sort="Ali, Imad M" uniqKey="Ali I" first="Imad M." last="Ali">Imad M. Ali</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:33AEC66DA30E8194BEE3C6A21657E9A6B7D7C457</idno>
<date when="2006" year="2006">2006</date>
<idno type="doi">10.1002/mds.21025</idno>
<idno type="url">https://api.istex.fr/document/33AEC66DA30E8194BEE3C6A21657E9A6B7D7C457/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">003D52</idno>
<idno type="wicri:Area/Istex/Curation">003D52</idno>
<idno type="wicri:Area/Istex/Checkpoint">002048</idno>
<idno type="wicri:doubleKey">0885-3185:2006:Wickremaratchi M:aripiprazole:associated:with</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:16817207</idno>
<idno type="wicri:Area/PubMed/Corpus">002B68</idno>
<idno type="wicri:Area/PubMed/Curation">002B68</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002E76</idno>
<idno type="wicri:Area/Ncbi/Merge">001769</idno>
<idno type="wicri:Area/Ncbi/Curation">001769</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">001769</idno>
<idno type="wicri:doubleKey">0885-3185:2006:Wickremaratchi M:aripiprazole:associated:with</idno>
<idno type="wicri:Area/Main/Merge">004902</idno>
<idno type="wicri:Area/Main/Curation">003587</idno>
<idno type="wicri:Area/Main/Exploration">003587</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Aripiprazole associated with severe exacerbation of Parkinson's disease</title>
<author><name sortKey="Wickremaratchi, Mirdhu" sort="Wickremaratchi, Mirdhu" uniqKey="Wickremaratchi M" first="Mirdhu" last="Wickremaratchi">Mirdhu Wickremaratchi</name>
<affiliation wicri:level="1"><country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Neurology, Ophthalmology, and Audiological Medicine, School of Medicine, Cardiff University, Wales</wicri:regionArea>
<wicri:noRegion>Wales</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Morris, Huw R" sort="Morris, Huw R" uniqKey="Morris H" first="Huw R." last="Morris">Huw R. Morris</name>
<affiliation wicri:level="1"><country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Neurology, Ophthalmology, and Audiological Medicine, School of Medicine, Cardiff University, Wales</wicri:regionArea>
<wicri:noRegion>Wales</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Ali, Imad M" sort="Ali, Imad M" uniqKey="Ali I" first="Imad M." last="Ali">Imad M. Ali</name>
<affiliation wicri:level="1"><country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Mental Health Unit, Royal Glamorgan Hospital Ynysmaerdy, Llantrisant</wicri:regionArea>
<wicri:noRegion>Llantrisant</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="sub">Official Journal of the Movement Disorder Society</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2006-09">2006-09</date>
<biblScope unit="vol">21</biblScope>
<biblScope unit="issue">9</biblScope>
<biblScope unit="page" from="1538">1538</biblScope>
<biblScope unit="page" to="1539">1539</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">33AEC66DA30E8194BEE3C6A21657E9A6B7D7C457</idno>
<idno type="DOI">10.1002/mds.21025</idno>
<idno type="ArticleID">MDS21025</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antipsychotic Agents (adverse effects)</term>
<term>Antipsychotic Agents (therapeutic use)</term>
<term>Dyskinesia, Drug-Induced (diagnosis)</term>
<term>Female</term>
<term>Humans</term>
<term>Middle Aged</term>
<term>Neurologic Examination (drug effects)</term>
<term>Parkinson Disease (drug therapy)</term>
<term>Parkinsonian Disorders (chemically induced)</term>
<term>Parkinsonian Disorders (diagnosis)</term>
<term>Piperazines (adverse effects)</term>
<term>Piperazines (therapeutic use)</term>
<term>Psychotic Disorders (drug therapy)</term>
<term>Quinolones (adverse effects)</term>
<term>Quinolones (therapeutic use)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Antipsychotic Agents</term>
<term>Piperazines</term>
<term>Quinolones</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antipsychotic Agents</term>
<term>Piperazines</term>
<term>Quinolones</term>
</keywords>
<keywords scheme="MESH" qualifier="chemically induced" xml:lang="en"><term>Parkinsonian Disorders</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Dyskinesia, Drug-Induced</term>
<term>Parkinsonian Disorders</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Neurologic Examination</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Parkinson Disease</term>
<term>Psychotic Disorders</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Female</term>
<term>Humans</term>
<term>Middle Aged</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
</TEI>
<affiliations><list><country><li>Royaume-Uni</li>
</country>
</list>
<tree><country name="Royaume-Uni"><noRegion><name sortKey="Wickremaratchi, Mirdhu" sort="Wickremaratchi, Mirdhu" uniqKey="Wickremaratchi M" first="Mirdhu" last="Wickremaratchi">Mirdhu Wickremaratchi</name>
</noRegion>
<name sortKey="Ali, Imad M" sort="Ali, Imad M" uniqKey="Ali I" first="Imad M." last="Ali">Imad M. Ali</name>
<name sortKey="Morris, Huw R" sort="Morris, Huw R" uniqKey="Morris H" first="Huw R." last="Morris">Huw R. Morris</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003587 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003587 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:33AEC66DA30E8194BEE3C6A21657E9A6B7D7C457
   |texte=   Aripiprazole associated with severe exacerbation of Parkinson's disease
}}

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024

Movement Disorders (revue)

Aripiprazole associated with severe exacerbation of Parkinson's disease

Aripiprazole associated with severe exacerbation of Parkinson's disease

Source :

English descriptors

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

	Movement Disorders (revue)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.